Open Access Highly Accessed Pre-publication history

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Pablo Ureña-Torres*, Dominique Prié, Karim Keddad, Peter Preston, Paul Wilde, Hong Wan and J Brian Copley

BMC Nephrology 2014, 15:71  doi:10.1186/1471-2369-15-71

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 15 Nov 2013
Reviewer's Report Bjorn Meijers 04 Dec 2013
Reviewer's Report Carmine Zoccali 07 Dec 2013
Reviewer's Report Carmine Zoccali 07 Dec 2013
Reviewer's Report Carmine Zoccali 07 Dec 2013
Reviewer's Report Carmine Zoccali 07 Dec 2013
Reviewer's Report Carmine Zoccali 07 Dec 2013
Reviewer's Report Carmine Zoccali 07 Dec 2013
Reviewer's Report Jessica Kendrick 18 Dec 2013
Resubmission - Version 2 Manuscript Author's comment 13 Feb 2014
Resubmission - Version 3 Manuscript Author's comment 15 Feb 2014
Reviewer's Report Carmine Zoccali 02 Mar 2014
Reviewer's Report Bjorn Meijers 04 Mar 2014
Reviewer's Report Jessica Kendrick 08 Mar 2014
Resubmission - Version 4 Manuscript Author's comment 24 Mar 2014
Resubmission - Version 5 Manuscript Author's comment 14 Apr 2014
Editorial acceptance 24 Apr 2014
Published 05 May 2014